Skip to main content
SpringerLink
Log in

Long-term follow-up of diffuse membranoproliferative glomerulonephritis type I

  • Original Article
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

Abstract

In Japan, the school urinary screening system facilitates early detection and treatment of membranoproliferative glomerulonephritis (MPGN) in childhood. The present study investigated the long-term prognosis in 19 children with diffuse MPGN type I who received steroid therapy. Before signs of glomerulonephritis were confirmed, all patients displayed abnormal urinalysis results, predominantly through school urinary screening. Treatment comprised a regimen of alternate-day prednisolone after steroid pulse or cyclophosphamide therapy, and follow-up was continued for 10–24 years. Excluding 1 patient on short-term therapy, 18 patients received long-term alternate-day prednisolone therapy for 4–12 years. Treatment was discontinued when amelioration was confirmed on renal biopsy. As of the last observation, urinary abnormalities and hypocomplementemia had disappeared in 15 patients, while mild proteinuria without hypocomplementemia remained in 4 patients. No patients required hemodialysis. Moreover, no severe adverse effects attributable to treatment were identified other than mild short stature. Early detection and therapy using pulse methylprednisolone followed by alternate-day prednisolone was thus confirmed as safe and useful for treating diffuse MPGN type I.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Abbreviations

MPGN:

membranoproliferative glomerulonephritis

References

  1. Cameron JS, Turner DR, Heaton J, Williams DG, Ogg CS, Chantler C, Haycock GB, Hicks J (1983) Idiopathic mesangiocapillary glomerulonephritis. Comparison of types I and II in children and adults and long-term prognosis. Am J Med 74:175–192

    Google Scholar 

  2. McEnery PT (1990) Membranoproliferative glomerulonephritis: the Cincinnati experience—cumulative renal survival from 1957 to 1989. J Pediatr 116:S109–114

    Google Scholar 

  3. Tarshish P, Bernstein J, Tobin JN, Edelmann CM Jr (1992) Treatment of mesangiocapillary glomerulonephritis with alternate-day prednisone—a report of the International Study of Kidney Disease in Children. Pediatr Nephrol 6:123–130

    Google Scholar 

  4. Ito T, Hasegawa O, Hatsukano H, Sakaguchi H (1978) Evaluation of methylprednisolone pulse therapy in membranoproliferative glomerulonephritis. Nippon Jinzo Gakkai Shi 20:682–685

    Google Scholar 

  5. Bergstein JM, Andreoli SP (1995) Response of type I membranoproliferative glomerulonephritis to pulse methylprednisolone and alternate-day prednisone therapy. Pediatr Nephrol 9:268–271

    Google Scholar 

  6. Iitaka K, Ishidate T, Hojo M, Kuwao S, Kasai N, Sakai T (1995) Idiopathic membranoproliferative glomerulonephritis in Japanese children. Pediatr Nephrol 9:272–277

    Google Scholar 

  7. Kawasaki Y, Suzuki J, Nozawa R, Suzuki H (2002) Efficacy of school urinary screening for membranoproliferative glomerulonephritis type 1. Arch Dis Child 86:21–25

    Google Scholar 

  8. Chapman SJ, Cameron JS, Chantler C, Turner D (1980) Treatment of mesangiocapillary glomerulonephritis in children with combined immunosuppression and anticoagulation. Arch Dis Child 55:446–451

    Google Scholar 

  9. Zimmerman SW, Moorthy AV, Dreher WH, Friedman A, Varanasi U (1983) Prospective trial of warfarin and dipyridamole in patients with membranoproliferative glomerulonephritis. Am J Med 75:920–927

    Google Scholar 

  10. Donadio JV Jr, Anderson CF, Mitchell JC 3rd, Holley KE, Ilstrup DM, Fuster V, Chesebro JH (1984) Membranoproliferative glomerulonephritis. A prospective clinical trial of platelet-inhibitor therapy. N Engl J Med 310:1421–1426

    Google Scholar 

  11. Faedda R, Satta A, Tanda F, Pirisi M, Bartoli E (1994) Immunosuppressive treatment of membranoproliferative glomerulonephritis. Nephron 67:59–65

    Google Scholar 

  12. Cattran DC, Cardella CJ, Roscoe JM, Charron RC, Rance PC, Ritchie SM, Corey PN (1985) Results of a controlled drug trial in membranoproliferative glomerulonephritis. Kidney Int 27:436–441

    Google Scholar 

  13. Ford DM, Briscoe DM, Shanley PF, Lum GM (1992) Childhood membranoproliferative glomerulonephritis type I: limited steroid therapy. Kidney Int 41:1606–1612

    Google Scholar 

  14. Zauner I, Bohler J, Braun N, Grupp C, Heering P, Schollmeyer P (1994) Effect of aspirin and dipyridamole on proteinuria in idiopathic membranoproliferative glomerulonephritis: a multicentre prospective clinical trial. Collaborative Glomerulonephritis Therapy Study Group (CGTS). Nephrol Dial Transplant 9:619–622

    Google Scholar 

  15. Strife CF, McAdams AJ, West CD (1982) Membranoproliferative glomerulonephritis characterized by focal, segmental proliferative lesions. Clin Nephrol 18:9–16

    Google Scholar 

  16. Watson AR, Poucell S, Thorner P, Arbus GS, Rance CP, Baumal R (1984) Membranoproliferative glomerulonephritis type I in children: correlation of clinical features with pathologic subtypes. Am J Kidney Dis 4:141–146

    Google Scholar 

  17. Kashtan CE, Burke B, Burch G, Gustav Fisker S, Kim Y (1990) Dense intramembranous deposit disease: a clinical comparison of histological subtypes. Clin Nephrol 33:1–6

    Google Scholar 

  18. Heptinstall RH (1966) The Nephrotic syndrome, chapter 13. In: Heptinstall RH (ed) Pathology of the kidney, 1st edn. Little, Brown and Company, Boston, pp 355–396

  19. West CD (1992) Idiopathic membranoproliferative glomerulonephritis in childhood. Pediatr Nephrol 6:96–103

    Google Scholar 

  20. Levin A (1999) Management of membranoproliferative glomerulonephritis: evidence-based recommendations. Kidney Int [Suppl] 70:S41–46

    Google Scholar 

  21. Schmitt H, Cavalcanti de Oliveira V, Bohle A (1987) Tubulo-interstitial alterations in type I membranoproliferative glomerulonephritis. An investigation of 259 cases. Pathol Res Pract 182:6–10

    Google Scholar 

  22. Donadio JV Jr, Offord KP (1989) Reassessment of treatment results in membranoproliferative glomerulonephritis, with emphasis on life-table analysis. Am J Kidney Dis 14:445–451

    Google Scholar 

  23. Iitaka K, Saka T, Yagisawa K, Aoki Y (2000) Decreasing hypocomplementemia and membranoproliferative glomerulonephritis in Japan. Pediatr Nephrol 14:794–796

    Google Scholar 

  24. Yalcinkaya F, Tumer N, Cakar N, Ekim M (1994) Paediatric membranoproliferative glomerulonephritis is not decreasing in Turkey! Pediatr Nephrol 8:131–132

    Google Scholar 

  25. Kumar J, Gulati S, Sharma AP, Sharma RK, Gupta RK (2003) Histopathological spectrum of childhood nephrotic syndrome in Indian children. Pediatr Nephrol 18:657–660

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pediatrics, Nippon Medical School, 1-1-5 Sendagi, Bunkyo-ku, 113-8602, Tokyo, Japan

    Takeshi Yanagihara, Mari Hayakawa, Junko Yoshida, Masami Tsuchiya, Mutsumi Murakami & Yoshitaka Fukunaga

  2. Department of Pediatrics, Shizuoka Medical Center, Shizuoka, Japan

    Takeshi Yanagihara & Toshisada Morita

Authors
  1. Takeshi Yanagihara
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mari Hayakawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Junko Yoshida
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Masami Tsuchiya
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Toshisada Morita
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Mutsumi Murakami
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Yoshitaka Fukunaga
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Takeshi Yanagihara.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yanagihara, T., Hayakawa, M., Yoshida, J. et al. Long-term follow-up of diffuse membranoproliferative glomerulonephritis type I. Pediatr Nephrol 20, 585–590 (2005). https://doi.org/10.1007/s00467-005-1826-8

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00467-005-1826-8

Keywords

Search

Navigation